Related Experiment Video

Updated: Aug 12, 2026

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
11:42

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

von Willebrand disease: recent advances in pathophysiology and treatment

M D Phillips1, A Santhouse

  • 1Centeon, L.L.C., King of Prussia, Pennsylvania 19406-1310, USA. phillmd@centeon.com

The American Journal of the Medical Sciences
|August 15, 1998
PubMed

Insights

This review covers new insights into von Willebrand disease (vWD) pathophysiology and treatments. It highlights vWD

Area of Science:

  • Hematology
  • Genetics
  • Cell Biology

Background:

  • Von Willebrand disease (vWD) is a common inherited bleeding disorder.
  • Prevalence estimates suggest up to 1% of the population may be affected, with significant implications for women's health.
  • Blood group O is associated with lower von Willebrand factor (vWF) levels.

Purpose of the Study:

  • To review recent advancements in understanding the pathophysiology of vWD.
  • To discuss current and emerging treatment strategies for vWD.
  • To explore the latest diagnostic methods and special considerations in vWD management.

Main Methods:

  • Literature review of recent studies on vWD.
  • Analysis of new findings in vWF cell biology, gene regulation, and structure-function relationships.
  • Discussion of diagnostic tests and therapeutic interventions.

Main Results:

  • vWD is more prevalent than previously thought, impacting diverse patient groups.
  • Blood group influences vWF levels, with implications for diagnosis and management.
  • Advances in understanding vWF biology are informing new treatment approaches.

Conclusions:

  • Updated knowledge of vWF pathophysiology is crucial for effective vWD management.
  • A range of treatments exist for classical and acquired vWD, with ongoing research.
  • Special populations, such as pregnant women, require tailored management strategies for vWD.

More Related Videos

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on: August 14, 2017

Pneumococcus Infection of Primary Human Endothelial Cells in Constant Flow09:34

Pneumococcus Infection of Primary Human Endothelial Cells in Constant Flow

Published on: October 31, 2019

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...